![Senator Rand Paul, a Republican from Kentucky, listens during a Senate Foreign Relations Committee hearing](https://www.statnews.com/wp-content/uploads/2022/10/GettyImages-1240251774-645x645.jpg)
WASHINGTON — In this year’s midterms, the future of federal science policy is in Republicans’ crosshairs.
Some of the most vocal critics of scientists and science agencies like the NIH and the CDC, including Sen. Rand Paul of Kentucky, are poised to ascend to powerful committee chairmanships that will enable them to conduct sweeping investigations and put health officials on public trial. The new chairmanships could also give them the ability to tighten the purse strings for health agencies’ budgets — and to deny funding outright for new Covid-19 measures or other Biden health priorities. At the same time, some of the Republican party’s biggest defenders of science and science policy are poised to retire.
Anthony Fauci is an obvious and already-declared target. But beyond the expected litany of coronavirus-related probes, Republican staffers and lobbyists familiar with the discussions tell STAT that Republican leaders plan to throw the spotlight on spending and transparency at health agencies from the Centers for Disease Control and Prevention to the Centers for Medicare & Medicaid Services.
Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us on Twitter, Facebook, LinkedIn, and Threads. Let's stay connected!
To submit a correction request, please visit our Contact Us page.